Suraksha Diagnostic Limited IPO
MainboardHealthcare Service Provider
Listed On: Dec 6, 2024 at ₹ 438.0(NSE)
₹ 14994 /34 Shares
Check AllotmentPrice Summary
Last Closing
392.75 (-10.94%)52 Week High
449.0052 Week Low
390.20Last Update
26-Dec-2024 3:30 PM29 Nov, 2024
Open Date03 Dec, 2024
Close Date04 Dec, 2024
Allotment Date06 Dec, 2024
Listing DateIssue Price
₹420-441 per equity shareFace Value
₹2 Per Equity ShareListing at Group
BSE, NSERegistrar
Kfin Technologies LimitedList Price
438.0(NSE)Listing Date
2024-12-06Market Lot
Retail : 34 Shares (₹14,994/-)S-HNI : 476 Shares (₹2,09,916/-)
B-HNI : 2,278 Shares (₹10,04,598/-)
Lead Manager
ICICI Securities LimitedNuvama Wealth Management Limited
SBI Capital Markets Limited
Issue Size
OFS : 19,189,330 shares of ₹2(aggregating up to ₹846.2 Crores)Retail Portion
35% (Number of Retail Applications: 1,97,357 Approx),(Number of S-HNI Applications : 2,016 Approx),
(Number of B-HNI Applications : 4,031 Approx)
Subscription
1.27 timesSuraksha Diagnostic IPO Subscription Details
As on | QIB | NII bNII sNII | Retail | Total |
---|---|---|---|---|
Shares Offered / Reserved | 3,837,867 | 2,878,400 1,918,934 959,466 | 6,716,266 | 13,432,533 |
Day 1 - 29-11-24 05:00 PM | 0.00 x | 0.04 0.02 x 0.08 x | 0.20 x | 0.11 x |
Day 2 - 02-12-24 05:00 PM | 0.00 x | 0.13 0.08 x 0.23 x | 0.45 x | 0.25 x |
Day 3 - 03-12-24 05:00 PM | 1.74 x | 1.40 1.53 x 1.16 x | 0.94 x | 1.27 x |
Suraksha Diagnostic Valuations
Earnings Per Share (EPS)
₹4.44/-P/E Ratio
99.31RoNW
14.09%Net Asset Value (NAV) - As on 31.03.22
₹N/ASuraksha Diagnostic Company Financials All values are in ₹ Cr.
31-Mar-24 | 31-Mar-23 | 31-Mar-22 | |
---|---|---|---|
Assets | 300.21 | 281.20 | 275.96 |
Revenue | 222.26 | 193.69 | 225.77 |
Profit After Tax | 23.13 | 6.07 | 20.82 |
About The Company
On March 15, 2005, Suraksha Diagnostic Limited began its operation as a leading technology-driven diagnostic chain in India. The company provides integrated pathology, radiology, and medical consultancy services under one umbrella with an excellent operational network. As of date, more than 2,300 specialized tests in various disciplines of medicine meet diverse health needs.
Comprehensive Diagnostic Network:Suraksha Diagnostic runs a state-of-the-art central reference laboratory supported by 8 satellite laboratories and 194 customer contact points, including 48 diagnostic centers and 146 sample collection centers. This extensive infrastructure thus provides seamless patient experience, convenient and accessible across eastern and northeastern India.
Besides offering diagnostic services, over 120 polyclinics function in 43 diagnostic centers with more than 750 doctors across the organization to offer in-house medical consultations for improving patient care.
Suraksha Diagnostic - Strength and Weakness
Leading presence in eastern India’s diagnostic market with growth potential in a fragmented industry.
Provides comprehensive diagnostics, including pathology, radiology, and consultations.
Recognized brand with a focus on quality, supporting individual consumer business.
Equipped with advanced clinical infrastructure and skilled personnel for reliable services.
The company’s business relies heavily on West Bengal, and any loss of business in this region may negatively impact overall performance.
The company depends on third-party vendors for testing equipment, and supply disruptions could affect operations.
The diagnostics industry is highly competitive, which could lead to price cuts that affect profits.
Suraksha Diagnostic - Peers Comparison
P/B Ratio | P/E Ratio | RoNW | Net Worth | |
---|---|---|---|---|
Suraksha Diagnostic | 12.6 | 99.3 | 14.1% | 222 |
Dr Lal Pathlabs | 12.7 | 63.5 | 20.4% | 2,346 |
Metropolis Healthcare | 9.28 | 74.4 | 12.2% | 1,285 |
Thyrocare Tech | 11.2 | 60.0 | 13.3% | 571 |
Vijaya Diagnostic | 16.1 | 87.2 | 17.8% | 627 |
Suraksha Diagnostic - Promoter(s)
Pre Issue Share Holding: N/A%
Post Issue Share Holding: N/A%
- Dr. Somnath Chatterjee
- Ritu Mittal
- Satish Kumar Verma
Suraksha Diagnostic IPO - Issue Objectives
- The Company will not receive any proceeds from the Offer for sale and all proceeds will go to the Selling Shareholders.
Suraksha Diagnostic IPO - Anchor Investors
Nippon Life India, Kotak Mutal Fund, Aditya Birla Sun Life Trustee, and Quant Mutual Fund are the biggest investors in the company through anchor book, acquiring 7.93 lakh equity shares worth Rs 35 crore each, while Carnelian Bharat Amritkaal Fund picked 6.8 lakh shares worth Rs 30 crore.
Mirae Asset, JM Financial, Bandhan Mutual Fund, Troo Capital, Intergrated Core Strategies, Tusk Investments Equity Fund, and Societe Generale are other investors participated in the anchor book.
Other Details
Suraksha Diagnostic
Plot No. DG-12/1, Action Area 1D, Premises No. 02-0327, New Town, Rajarhat Kolkata 700 156Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: sdl.ipo@kfintech.com
Suraksha Diagnostic IPO - FAQs
Ans. Suraksha Diagnostic Limited IPO is a Mainboard IPO. The issue is priced at ₹420-441 per equity share. The minimum order quantity is 34 Shares. The IPO opens on Nov 29, 2024, and closes on Dec 3, 2024. Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Ans. The Suraksha Diagnostic Limited IPO opens on Nov 29, 2024 and closes on Dec 3, 2024.
Ans. The size of Suraksha Diagnostic Limited IPO is OFS : 19,189,330 shares of ₹2(aggregating up to ₹846.2 Crores).
Ans. The IPO price band is set between ₹420-441 per equity share.
Ans. To apply for Suraksha Diagnostic Limited IPO IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Suraksha Diagnostic Limited IPO in the List of IPOs
- - Press "Apply" Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Suraksha Diagnostic Limited IPO is Dec 4, 2024.
Ans. The Suraksha Diagnostic Limited IPO will be listed on Dec 6, 2024.
Ans. Follow the steps to check the allotment status for Suraksha Diagnostic Limited IPO here.